NECTAR LIFESCIENCES LTD.

NSE : NECLIFEBSE : 532649ISIN CODE : INE023H01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE30.110.06 (+0.2 %)
PREV CLOSE ( ) 30.05
OPEN PRICE ( ) 30.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43968
TODAY'S LOW / HIGH ( )30.05 30.65
52 WK LOW / HIGH ( )14.36 45.7
NSE30.150.05 (+0.17 %)
PREV CLOSE( ) 30.10
OPEN PRICE ( ) 30.15
BID PRICE (QTY) 30.15 (2801)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 541696
TODAY'S LOW / HIGH( ) 30.05 30.75
52 WK LOW / HIGH ( )14.5 45.7

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.